Advanced in Cholangiocarcinoma (Bile Duct Cancer)

Yudong P. Qiu

No. 321 Zhongshan Road, 
Nanjing, CN 
Advanced in Cholangiocarcinoma (Bile Duct Cancer)
No. 321 Zhongshan Road, 
Nanjing, CN 
OverviewLocationsClinical Research

Overview

Yudong Qiu practices in Nanjing, China. Qiu is rated as an Advanced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Their top areas of expertise are Lordosis, Scoliosis, Kyphosis, Pancreaticoduodenectomy, and Spinal Fusion.

Their clinical research consists of co-authoring 163 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 16 articles and participated in 1 clinical trial in the study of Cholangiocarcinoma (Bile Duct Cancer).

Locations

No. 321 Zhongshan Road, Nanjing, 210008, China
Other Locations
155 Hanzhong Road, Nanjing, 210029, China
Zhongshan Road 321, Nanjing, 210008, China
301 Yanchang Middle Road, Shanghai, 201203, China
389 Xin Cun Road, Putuo, 200065, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, RCT Evaluating the Safety and Hemostatic Effectiveness of SURGICEL Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding During Surgery in Chinese Adult Subjects
A Prospective, RCT Evaluating the Safety and Hemostatic Effectiveness of SURGICEL Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding During Surgery in Chinese Adult Subjects
Enrollment Status: Completed
Publish Date: July 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
Multi-center, Randomized, Controlled, Open-label Study of Deuteporfin Photodynamic Therapy Plus Stenting Versus Stenting Alone as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma
Multi-center, Randomized, Controlled, Open-label Study of Deuteporfin Photodynamic Therapy Plus Stenting Versus Stenting Alone as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: July 17, 2019
Intervention Type: Combination product, Device
Study Phase: Phase 2
View 1 Less Clinical Trial

163 Total Publications

Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection.
Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection.
Journal: Annals of medicine
Published: August 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Qiu's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile